ABBV vs AMD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Advanced Micro Devices, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C
High Quality
VS
Advanced Micro Devices, Inc. · Technology
$341.54
+38.2% upside to fair value
Grade C
High Quality
QuantHub Verdict
AMD has more upside to fair value
(+38.2%).
ABBV trades at a lower forward P/E
(83.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMD |
| Current Price |
$197.69 |
$341.54 |
| Fair Value Estimate |
$210.22 |
$472.05 |
| Upside to Fair Value |
+6.3%
|
+38.2%
|
| Market Cap |
$349.7B |
$556.9B |
| Forward P/E |
83.3x
|
128.4x
|
| EV / EBITDA |
23.4x
|
76.3x
|
| Price / Sales |
5.7x
|
16.1x
|
| Price / FCF |
18.7x
|
82.7x
|
| Revenue Growth YoY |
+10.0%
|
+34.1%
|
| Gross Margin |
70.2%
|
49.5%
|
| Operating Margin |
26.7%
|
10.7%
|
| Return on Equity |
-361.6%
|
7.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.35%
|
1.21%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
Advanced Micro Devices, Inc. is a leading semiconductor company specializing in high-performance computing products including CPUs and GPUs, with a strong foothold in data center, client, gaming, and embedded markets. The company benefits from a durable competitive moat driven by its technology leadership in Zen/Ryzen CPUs and graphics processors, as well as strategic diversification through the …
Accumulation Zones
| Metric |
ABBV |
AMD |
| Zone Low |
$157.66 |
$354.04 |
| Zone High |
$178.69 |
$401.24 |
| In Buy Zone? |
No
|
Yes
|